Cath Lab

The catheterization lab channel includes content related to interventional technologies for coronary and peripheral artery disease (PAD). Other cath lab transcatheter device technologies covered on this page included percutaneous treatment for stroke, venous interventions, heart valves, hypertensionheart failure and percutenous coronary interventions (PCI).

Canon Medical Debuts Alphenix 4-D CT at RSNA 2018
Technology | Angiography | February 06, 2019

February 6, 2019 — Canon Medical Systems USA Inc. recently introduced a new...

Edwards Lifesciences Recalls Swan-Ganz hemodynamic catheters.
Feature | Cath Lab | February 06, 2019

Edwards Lifesciences is recalling its 131F7, 131F7J, 131F7P, 131VF7P, 151F7 Swan-Ganz Thermodilution Catheters...

Delayed Clot Removal Still Improves Quality of Life Post-Stroke
News | Thrombectomy Devices | February 05, 2019

February 5, 2019  — Stroke survivors have...

The Abiomed Impella RP had higher than expected mortality in its post approval study, much higher than in its pre-market approval study. The vendor and the FDA believe this might be due to poor patient selection and implanting the device too late to aid the patient.

The Abiomed Impella RP had higher than expected mortality in its post-approval study, much higher than in its pre-market approval study. The vendor and the FDA believe this might be due to poor patient selection and implanting the device too late to aid the patient.

Feature | Hemodynamic Support Devices | February 05, 2019 | Dave Fornell, Editor

The U.S. Food and Drug Administration (FDA) sent a letter to cardiologists this week to explain its evaluation of...

Canon Medical Systems Launches Alphenix Interventional Imaging Line
Technology | Angiography | February 04, 2019

February 4, 2019 — Canon Medical Systems USA recently introduced its next generation of...

Two of the top news items from January included news atrial fibrillation guidelines that now recommend new anticoagulants (NOACs) over warfarin, and the FDA warning hospitals about the increased mortality found in one study involving pacitaxel-eluting stents and balloon devices for the peripheral arteries.

Two of the top news items from January included news atrial fibrillation guidelines that now recommend new anticoagulants (NOACs) over warfarin, and the FDA warning hospitals about the increased mortality found in one study involving pacitaxel-eluting stents and balloon devices for the peripheral arteries. 

Feature | February 01, 2019 | Dave Fornell, Editor

February 1, 2019 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (...

PreludeSync Distal Compression Device Available Globally
Technology | Hemostasis Management | February 01, 2019

February 1, 2019 — Merit Medical Systems Inc. announced that the PreludeSync Distal Compression Device is now...

First U.S. Patients Treated With OrbusNeich Teleport Microcatheter
News | Catheters | January 31, 2019

January 31, 2019 — Cardiovascular Systems Inc. announced that the first patients in the United States were treated...

A view of GE Healthcare's volume max, or Vmax, which allows for nearly triple the frame rate speeds on 3-D TEE in a single beat over previous generation systems.

A view of GE Healthcare's volume max, or Vmax, which allows for nearly triple the frame rate speeds on 3-D TEE in a single beat over previous-generation systems.  

Feature | Cardiovascular Ultrasound | January 31, 2019 | Dave Fornell, Editor

The higher expense and lower frame rates of 3-D...

Scientists Discover New Heart Attack Repair Pathway

A macrophage immune cell, with a dead cell (pink) that has been eaten, and a mitochondrion (green) between the dead cell and the nucleus. The study’s findings indicate that what the macrophage eats is taken up by the mitochondrion, which in turn communicates with the nucleus to activate the macrophage to promote tissue repair. Image courtesy of Northwestern Medicine.

News | Cath Lab | January 30, 2019

January 30, 2019 — Northwestern Medicine scientists have discovered a novel signaling pathway that promotes healing...

The Boston Scientific Eluvia self-expanding, drug-eluting peripheral stent. It outperformed the Cook Zilver stent in the IMPERIAL Trial presented at TCT 2018.

The Boston Scientific Eluvia self-expanding, drug-eluting peripheral stent. It outperformed the Cook Zilver stent in the IMPERIAL Trial presented at TCT 2018.

Feature | Peripheral Artery Disease (PAD) | January 30, 2019 | Dave Fornell, Editor

In recent years, there has been a lot of focus by vendors on developing better stenting technologies to treat...

FDA Clears XableCath Crossing Catheters
Technology | Chronic Total Occlusion (CTO) | January 30, 2019

January 30, 2019 — XableCath Inc., announced that its XableCath blunt and abrasion tip catheters were cleared by the...

Thubrikar Announces First-in-Human Implant of Optimum TAVI System
News | Heart Valve Technology | January 29, 2019

January 29, 2019 — Thubrikar Aortic Valve Inc. announced the first human implant of the Optimum TAV using their...

The Medtronic Resolute Integrity drug-eluting stent is among the top three stents on the U.S. market. Outcomes for these stents are very similar, so the stents have largely become a commodity product purchased on price rather than clinical data. Stent advances and new stent technologies.

The Medtronic Resolute Integrity drug-eluting stent (DES) is among the top three stents on the U.S. market. Outcomes for these stents are very similar, so the stents have largely become a commodity product purchased on price rather than clinical data.

Feature | Stents | January 29, 2019 | Dave Fornell, Editor

There was a lot of hype and high hopes pinned on bioresorbable stent technologies as the way of the future two years...

An example of multimodality image fusion with live angiography to enhance soft-tissue visualization during complex procedures. This example is from Siemen's new TrueFusion software released in 2018. Advances in angiography imaging.

An example of multimodality image fusion with live angiography to enhance soft-tissue visualization during complex procedures. This example is from Siemen's new TrueFusion software released in 2018. 

Feature | Angiography | January 28, 2019 | Dave Fornell, Editor

There are a few recent trends in X-ray...

Overlay Init